Molecular Photoacoustic Imaging of Follicular Thyroid Carcinoma

Purpose: To evaluate the potential of targeted photoacoustic imaging as a noninvasive method for detection of follicular thyroid carcinoma. Experimental Design: We determined the presence and activity of two members of matrix metalloproteinase family (MMP), MMP-2 and MMP-9, suggested as biomarkers for malignant thyroid lesions, in FTC133 thyroid tumors subcutaneously implanted in nude mice. The imaging agent used to visualize tumors was MMP-activatable photoacoustic probe, Alexa750-CXeeeeXPLGLAGrrrrrXK-BHQ3. Cleavage of the MMP-activatable agent was imaged after intratumoral and intravenous injections in living mice optically, observing the increase in Alexa750 fluorescence, and photoacoustically, using a dual-wavelength imaging method. Results: Active forms of both MMP-2 and MMP-9 enzymes were found in FTC133 tumor homogenates, with MMP-9 detected in greater amounts. The molecular imaging agent was determined to be activated by both enzymes in vitro, with MMP-9 being more efficient in this regard. Both optical and photoacoustic imaging showed significantly higher signal in tumors of mice injected with the active agent than in tumors injected with the control, nonactivatable, agent. Conclusions: With the combination of high spatial resolution and signal specificity, targeted photoacoustic imaging holds great promise as a noninvasive method for early diagnosis of follicular thyroid carcinomas. Clin Cancer Res; 19(6); 1494–502. ©2013 AACR.

[1]  Vasilis Ntziachristos,et al.  Multispectral Optoacoustic Tomography of Matrix Metalloproteinase Activity in Vulnerable Human Carotid Plaques , 2011, Molecular Imaging and Biology.

[2]  Jesse V Jokerst,et al.  Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods. , 2012, ACS nano.

[3]  Sanjiv S Gambhir,et al.  Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. , 2007, Trends in molecular medicine.

[4]  Hisataka Kobayashi,et al.  Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. , 2011, Accounts of chemical research.

[5]  Younan Xia,et al.  Gold nanocages as contrast agents for photoacoustic imaging. , 2011, Contrast media & molecular imaging.

[6]  Roger Y Tsien,et al.  In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[7]  Sanjiv S Gambhir,et al.  Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice. , 2012, ACS nano.

[8]  Lihong V Wang,et al.  Photoacoustic tomography and sensing in biomedicine , 2009, Physics in medicine and biology.

[9]  S. Korem,et al.  Matrix metalloproteinases and the thyroid. , 2000, Thyroid : official journal of the American Thyroid Association.

[10]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[11]  M. Hamaguchi,et al.  Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions , 2006, Histopathology.

[12]  H. Allgayer,et al.  Urokinase receptor, MMP‐1 and MMP‐9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies , 2009, International journal of cancer.

[13]  N. Shibata,et al.  The role of CD147 in the invasiveness of follicular thyroid carcinoma cells. , 2012, Thyroid : official journal of the American Thyroid Association.

[14]  Sanjiv Sam Gambhir,et al.  AMIDE: a free software tool for multimodality medical image analysis. , 2003, Molecular imaging.

[15]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[16]  E. Marchioni,et al.  Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines. , 2004, Thyroid : official journal of the American Thyroid Association.

[17]  J. Netterville,et al.  Implications of Follicular Neoplasms, Atypia, and Lesions Suspicious for Malignancy Diagnosed by Fine-Needle Aspiration of Thyroid Nodules , 2002, Annals of surgery.

[18]  K. Nicolay,et al.  Tumor Targeting of MMP-2/9 Activatable Cell-Penetrating Imaging Probes Is Caused by Tumor-Independent Activation , 2011, The Journal of Nuclear Medicine.

[19]  Roger Y Tsien,et al.  Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[20]  E. Marinelli,et al.  Synthesis, in vitro evaluation, and in vivo metabolism of fluor/quencher compounds containing IRDye 800CW and Black Hole Quencher-3 (BHQ-3). , 2011, Bioconjugate chemistry.

[21]  Stanislav Emelianov,et al.  Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging. , 2012, ACS nano.

[22]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Te-Jen Ma,et al.  Design, synthesis, and imaging of an activatable photoacoustic probe. , 2010, Journal of the American Chemical Society.

[24]  Klara Stefflova,et al.  Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. , 2009, Journal of medicinal chemistry.